Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

107.95
+0.95000.89%
Volume:19.24K
Turnover:2.08M
Market Cap:12.25B
PE:31.92
High:107.96
Open:107.96
Low:107.95
Close:107.00
52wk High:111.15
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:4.85
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.35
PE(LYR):42.17

Loading ...

Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities